South Africa Fabry Disease Treatment Market Size & Outlook

The fabry disease treatment market in South Africa is expected to reach a projected revenue of US$ 9.4 million by 2027. A compound annual growth rate of 3.7% is expected of South Africa fabry disease treatment market from 2021 to 2027.
Revenue, 2020 (US$M)
$7.3
Forecast, 2027 (US$M)
$10.9
CAGR, 2021 - 2027
5.9%
Report Coverage
South Africa

South Africa fabry disease treatment market highlights

  • The South Africa fabry disease treatment market generated a revenue of USD 7.3 million in 2020 and is expected to reach USD 10.9 million by 2027.
  • The South Africa market is expected to grow at a CAGR of 5.9% from 2021 to 2027.
  • In terms of segment, replagal was the largest revenue generating product in 2020.
  • Galafold is the most lucrative product segment registering the fastest growth during the forecast period.


Fabry disease treatment market data book summary

Market revenue in 2020USD 7.3 million
Market revenue in 2027USD 10.9 million
Growth rate5.9% (CAGR from 2020 to 2027)
Largest segmentReplagal
Fastest growing segmentGalafold
Historical data2016 - 2019
Base year2020
Forecast period2021 - 2027
Quantitative unitsRevenue in USD million
Market segmentationGalafold, Fabrazyme, Replagal
Key market players worldwide3D Systems Corp, Formlabs, Voxeljet AG ADR


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.6% of the global fabry disease treatment market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
  • In Middle East & Africa, South Africa fabry disease treatment market is projected to lead the regional market in terms of revenue in 2027.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 5.3 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Fabry Disease Treatment Market Scope

Fabry disease treatment market segmentation & scope

Fabry Disease Treatment Market Companies

Name Profile # Employees HQ Website

South Africa fabry disease treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fabry disease treatment market will help companies and investors design strategic landscapes.


Replagal was the largest segment with a revenue share of 68.49% in 2020. Horizon Databook has segmented the South Africa fabry disease treatment market based on galafold, fabrazyme, replagal covering the revenue growth of each sub-segment from 2016 to 2027.


Reasons to subscribe to South Africa fabry disease treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Africa fabry disease treatment market databook

  • Our clientele includes a mix of fabry disease treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa fabry disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Africa fabry disease treatment market from 2016 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Africa fabry disease treatment market size, by product, 2016-2027 (US$M)

South Africa Fabry Disease Treatment Market Outlook Share, 2020 & 2027 (US$M)

South Africa fabry disease treatment market size, by product, 2016-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more